End points in advanced colon cancer clinical trials: A review and proposal Journal Article
| Authors: | Allegra, C.; Blanke, C.; Buyse, M.; Goldberg, R.; Grothey, A.; Meropol, N. J.; Saltz, L.; Venook, A.; Yothers, G.; Sargent, D. |
| Article Title: | End points in advanced colon cancer clinical trials: A review and proposal |
| Keywords: | disease-free survival; survival rate; clinical trial; bevacizumab; fluorouracil; cancer growth; note; human immunodeficiency virus infection; antineoplastic agent; sensory neuropathy; cetuximab; cancer therapy; irinotecan; monoclonal antibody; panitumumab; colorectal neoplasms; folinic acid; colon cancer; therapy delay; atypical antipsychotic agent; platinum derivative; antiretrovirus agent; drug substitution; endpoint determination; oxaliplatin; pyrimidine derivative; alzheimer disease; clinical trials |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 24 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-08-20 |
| Start Page: | 3572 |
| End Page: | 3575 |
| Language: | English |
| DOI: | 10.1200/jco.2007.12.1368 |
| PUBMED: | 17704403 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 30" - "Export Date: 17 November 2011" - "CODEN: JCOND" - "Source: Scopus" |
